ID: h-gap-2f2e5b80-m2
Hypothesis
plasma LPS-binding protein separates causal from compensatory states in: How does gut microbiome dysbiosis contribute to neuroinflammation and neurodegenerat
A longitudinal biomarker panel centered on plasma LPS-binding protein can distinguish harmful mechanisms from protective adaptation.
EvidencePending (0%)📖 6 cit🗣 2 debates✓ 6 support✗ 1 oppose
✓ All Quality Gates Passed
🧪 Overview
A longitudinal biomarker panel centered on plasma LPS-binding protein can distinguish harmful mechanisms from protective adaptation. The decisive experiment is to measure plasma LPS-binding protein before and after TLR4 antagonism in stratified models.
🧬 Mechanism
🧬 Curated Mechanism Pathway
Curated pathway from expert analysis
flowchart TD
A["Gut Dysbiosis<br/>SCFA-Producing Bacteria Loss"]
B["Intestinal Permeability<br/>Leaky Gut Endotoxemia"]
C["LPS Translocation<br/>Portal and Systemic Circulation"]
D["TLR4 Activation<br/>MD-2 Coreceptor Complex"]
E["MyD88 Signaling<br/>NF-kappaB and MAPK Cascade"]
F["Peripheral Cytokine Storm<br/>IL-1beta and TNF Secretion"]
G["Microglial Priming<br/>Brain Resident Immune Activation"]
H["Neurodegeneration<br/>Synapse Loss and Tau Pathology"]
A --> B
B --> C
C --> D
D --> E
E --> F
F --> G
G --> H
style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
style D fill:#7b1fa2,stroke:#ce93d8,color:#ce93d8
style G fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
style H fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a⚖️ Evidence
⚖️ Evidence Matrix5 supports1 contradicts
Supports
TLR4-dependent neuroinflammation mediates LPS-driven food-reward alterations during high-fat exposure.
Supports
Early glycolytic reprogramming controls microglial inflammatory activation.
Supports
Ferulic acid alleviates sciatica by inhibiting neuroinflammation and promoting nerve repair via the TLR4/NF-κB pathway.
Supports
Gastrodin regulates the TLR4/TRAF6/NF-κB pathway to reduce neuroinflammation and microglial activation in an AD model.
Supports
Lomerizine inhibits LPS-mediated neuroinflammation and tau hyperphosphorylation by modulating NLRP3, DYRK1A, and GSK3α/β.
Contradicts
causal direction requires longitudinal perturbation
skeptic_round
📖 Linked Papers (8)Export BibTeX ↗
Gastrodin regulates the TLR4/TRAF6/NF-κB pathway to reduce neuroinflammation and microglial activation in an AD model.
Phytomedicine : international journal of phytotherapy and phytopharmacology (2024) · PubMed:38552431 ↗
No figures
Gastrodin regulates the TLR4/TRAF6/NF-κB pathway to reduce neuroinflammation and microglial activation in an AD model.
Phytomedicine : international journal of phytotherapy and phytopharmacology (2024) · PubMed:38552431 ↗
No figures
Lomerizine inhibits LPS-mediated neuroinflammation and tau hyperphosphorylation by modulating NLRP3, DYRK1A, and GSK3α/β.
Frontiers in immunology (2023) · PubMed:37435081 ↗
No figures
Lomerizine inhibits LPS-mediated neuroinflammation and tau hyperphosphorylation by modulating NLRP3, DYRK1A, and GSK3α/β.
Frontiers in immunology (2023) · PubMed:37435081 ↗
No figures
Ferulic acid alleviates sciatica by inhibiting neuroinflammation and promoting nerve repair via the TLR4/NF-κB pathway.
CNS neuroscience & therapeutics (2023) · PubMed:36601662 ↗
No figures
Ferulic acid alleviates sciatica by inhibiting neuroinflammation and promoting nerve repair via the TLR4/NF-κB pathway.
CNS neuroscience & therapeutics (2023) · PubMed:36601662 ↗
No figures
Early glycolytic reprogramming controls microglial inflammatory activation.
Journal of neuroinflammation (2021) · PubMed:34107997 ↗
No figures
Early glycolytic reprogramming controls microglial inflammatory activation.
Journal of neuroinflammation (2021) · PubMed:34107997 ↗
No figures
🏥 Translation
🧬 3D Protein Structure — PLASMA
No curated PDB or AlphaFold mapping for PLASMA yet. Search RCSB →
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for plasma LPS-binding protein.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↔
Stable
7d Momentum
▼ 0.8%
Volatility
High
0.1687
Events (7d)
3
Price History
▼4.4%💾 Resource Usage
No resource usage or linked notebooks recorded for this hypothesis yet.
🔮 Predictions
🔎 Predictions vs Observations2 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF plasma LPS-binding protein separates causal dysbiosis from compensation, THEN baseline LBP in high-dysbiosis participants will predict >=20% faster rise in plasma GFAP or NfL over 18 months. | Top-tertile LBP among dysbiotic participants predicts >=20% higher annual GFAP/NfL slope than bottom tertile. | — no observation — | pending | 0.58 |
| IF LBP marks harmful SCFA-depletion states, THEN restoring butyrate-producing taxa will lower plasma LBP by >=15% and microglial activation PET signal by >=10% within 12 weeks. | Butyrate-restoration intervention reduces LBP >=15% and TSPO-PET or equivalent neuroinflammation marker >=10%. | — no observation — | pending | 0.50 |
🔮 Falsifiable Predictions (2)
pendingconf 58%
IF plasma LPS-binding protein separates causal dysbiosis from compensation, THEN baseline LBP in high-dysbiosis participants will predict >=20% faster rise in plasma GFAP or NfL over 18 months.
Predicted outcome: Top-tertile LBP among dysbiotic participants predicts >=20% higher annual GFAP/NfL slope than bottom tertile.
Falsification: LBP tertiles differ by <5% in GFAP/NfL slope or association disappears after CRP/metabolic adjustment.
pendingconf 50%
IF LBP marks harmful SCFA-depletion states, THEN restoring butyrate-producing taxa will lower plasma LBP by >=15% and microglial activation PET signal by >=10% within 12 weeks.
Predicted outcome: Butyrate-restoration intervention reduces LBP >=15% and TSPO-PET or equivalent neuroinflammation marker >=10%.
Falsification: LBP falls <5% or neuroinflammation marker does not change despite verified SCFA increase.
▸Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesis
| source | v1_phase_c_backfill |
| origin_type | debate_synthesis |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.